超声引导下经皮射频消融治疗浆细胞性乳腺炎的疗效分析

Analysis of the effect of ultrasound-guided percutaneous radiofrequency ablation in the treatment of plasma cell mastitis

目的探讨超声引导下经皮射频消融治疗浆细胞性乳腺炎(PCM)的安全性及疗效。方法回顾性分析2021年1月至2022年12月郑州大学第一附属医院10例行超声引导下经皮穿刺射频消融治疗的PCM患者的临床资料。观察患者术后并发症情况、患者症状与体征及超声影像学表现,术后3个月治疗效果,术后1个月、3个月、6个月、12个月消融病灶的缩小率,术后1年内的复发情况及治疗效果满意度。结果10例PCM患者术后均未出现严重并发症,术后3个月治疗效果显著,术后1个月、3个月、6个月、12个月消融病灶的缩小率分别为32.31%~51.00%[(42.78±4.48)%]、70.66%~86.68%[(70.45±12.43)%]、72.31%~100%[(86.91±7.45)%]、89.13%~100%[(96.07±7.45)%]。10例患者术后3个月症状、体征均明显好转,随访期间无病情反复,疗效显著,治疗效果满意。结论超声引导下经皮射频消融治疗PCM是一种微创、有效且安全的治疗方法。

Objective To investigate the safety and efficacy of ultrasound-guided percutaneous radiofrequency ablation in the treatment of plasma cell mastitis.Methods A retrospective analysis was performed for the clinical data of 10 patients with plasma cell mastitis treated with ultrasound-guided percutaneous radiofrequency ablation in the First Affiliated Hospital of Zhengzhou University from January 2021 to December 2022.The postoperative complications,symptoms and signs of the patients,ultrasound imaging manifestations,treatment efficacy at 3 months after surgery,the reduction rate of ablation lesions at 1 month,3 months,6 months,and 12 months after surgery,the recurrence status within 1 year after surgery,and the satisfaction with the treatment effect were observed.Results The reduction rates of ablation lesions at 1 month,3 months,6 months,and 12 months were 32.31%-51.00%[(42.78±4.48)%],70.66%-86.68%[(70.45±12.43)%],72.31%-100%[(86.91±7.45)%],89.13%-100%[(96.07±7.45)%],respecctively.The symptoms and signs of 10 patients improved significantly 3 months after surgery,and there was no recurrence of the disease during the follow-up period,and the treatment effect was significant and satisfactory.Conclusions Ultrasound-guided percutaneous radiofrequency ablation for the treatment of plasma cell mastitis is a minimally invasive,effective and safe treatment.